COVID-19 as a putative trigger of anti-MDA5-associated dermatomyositis with acute respiratory distress syndrome (ARDS) requiring lung transplantation, a case report.
Karolina AnderleKlaus MacholdHans P KienerDaniel BormannKonrad HoetzeneckerSilvana GeleffHelmut ProschFranco LacconePeter M HeilPeter PetzelbauerDaniel AletahaStephan BlümlKastriot KastratiPublished in: BMC rheumatology (2022)
We report a unique case of a patient with a new-onset anti-MDA5 DM with fulminant ARDS emerging in a post-infectious stage of COVID-19, who underwent a successful lung transplantation and achieved remission. Given the high mortality of anti-MDA5 DM associated RP-ILD, we would like to highlight that the timely recognition of this condition and urgent therapy initiation are of utmost importance.
Keyphrases
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation
- mechanical ventilation
- coronavirus disease
- breast cancer cells
- sars cov
- interstitial lung disease
- disease activity
- case report
- intensive care unit
- cell cycle arrest
- cardiovascular events
- rheumatoid arthritis
- adipose tissue
- stem cells
- glycemic control
- mesenchymal stem cells
- skeletal muscle
- cell therapy